We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAZR
2101
DELISTED
Luminar Technologies
LAZR
$525K ﹤0.01%
7,064
+309
+5% +$33.6K
SVC
2102
Service Properties Trust
SVC
$1.06B
$525K ﹤0.01%
14,394
+442
+3% +$16.2K
BBBY
2103
Bed Bath & Beyond
BBBY
$423M
$522K ﹤0.01%
29,635
+1,666
+6% +$35.8K
IMGN
2104
DELISTED
Immunogen Inc
IMGN
$521K ﹤0.01%
105,050
+4,227
+4% +$22.9K
CMTG icon
2105
Claros Mortgage Trust
CMTG
$268M
$520K ﹤0.01%
35,382
+20,550
+139% +$323K
GSAT icon
2106
Globalstar
GSAT
$10.7B
$520K ﹤0.01%
26,090
+595
+2% +$15.6K
NSSC icon
2107
Napco Security Technologies
NSSC
$1.37B
$518K ﹤0.01%
18,851
+7,849
+71% +$212K
MOV icon
2108
Movado Group
MOV
$796M
$517K ﹤0.01%
16,030
+3,198
+25% +$102K
PBI icon
2109
Pitney Bowes
PBI
$2.28B
$517K ﹤0.01%
135,927
+26,667
+24% +$89.9K
MGI
2110
DELISTED
MoneyGram International, Inc. New
MGI
$516K ﹤0.01%
47,372
+570
+1% +$6.1K
RVLV icon
2111
Revolve Group
RVLV
$1.72B
$515K ﹤0.01%
23,157
+2,665
+13% +$64K
BJRI icon
2112
BJ's Restaurants
BJRI
$1.42B
$514K ﹤0.01%
19,469
-12,605
-39% -$368K
SLVM icon
2113
Sylvamo
SLVM
$1.55B
$514K ﹤0.01%
10,581
+1,943
+22% +$93.3K
GOLF icon
2114
Acushnet Holdings
GOLF
$5.25B
$513K ﹤0.01%
12,074
+447
+4% +$20.1K
CAL icon
2115
Caleres
CAL
$461M
$512K ﹤0.01%
22,997
+1,815
+9% +$44.5K
EGHT icon
2116
8x8 Inc
EGHT
$303M
$512K ﹤0.01%
118,536
+8,664
+8% +$34.8K
IJR icon
2117
iShares Core S&P Small-Cap ETF
IJR
$113B
$511K ﹤0.01%
5,403
+700
+15% +$67.1K
VBTX
2118
DELISTED
Veritex Holdings
VBTX
$510K ﹤0.01%
18,166
+638
+4% +$19K
BBIO icon
2119
BridgeBio Pharma
BBIO
$15.9B
$507K ﹤0.01%
66,522
-16,764
-20% -$161K
DLX icon
2120
Deluxe
DLX
$1.11B
$506K ﹤0.01%
29,818
+805
+3% +$14.3K
CNDT icon
2121
Conduent
CNDT
$252M
$505K ﹤0.01%
124,666
+3,484
+3% +$13.4K
SGMO
2122
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$503K ﹤0.01%
160,151
+5,015
+3% +$19.5K
HFWA icon
2123
Heritage Financial
HFWA
$1.23B
$501K ﹤0.01%
16,354
-3,749
-19% -$117K
TTMI icon
2124
TTM Technologies
TTMI
$14.6B
$501K ﹤0.01%
33,250
+54
+0.2% +$801
FCEL icon
2125
FuelCell Energy
FCEL
$1.63B
$500K ﹤0.01%
5,998
+322
+6% +$31K

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.